Article info
PDFReview
Plasma exchange in neurological disease
- Correspondence to Dr Chinar Osman, Neurosciences, Wessex Neurological Centre, Southampton SO16 6YD, UK; chinar.osman{at}uhs.nhs.uk
Citation
Plasma exchange in neurological disease
Publication history
- Accepted June 27, 2019
- First published July 12, 2019.
Online issue publication
August 10, 2020
Article Versions
- Previous version (17 March 2020).
- Previous version (17 March 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Therapeutic plasma exchange (TPE) for semi-critical neurology presentations in a non-acute neurology set-up: clinical practice and challenges
- Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition
- Autologous haematopoietic stem cell transplantation for neurological diseases
- INFLAMMATORY/POST-INFECTIOUS ENCEPHALOMYELITIS
- Rhomboencephalitis
- Intravenous immunoglobulin in neurological disease: a specialist review
- Neuromyelitis optica spectrum disorder presenting in an octogenarian
- Treatment of CIDP
- A nationwide survey of combined central and peripheral demyelination in Japan
- Pathophysiology, diagnosis, and management of neuroinflammation in covid-19